BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21114638)

  • 1. Response to second generation antipsychotics in youth with comorbid bipolar disorder and autism spectrum disorder.
    Joshi G; Biederman J; Wozniak J; Doyle R; Hammerness P; Galdo M; Sullivan N; Williams C; Brethel K; Woodworth KY; Mick E
    CNS Neurosci Ther; 2012 Jan; 18(1):28-33. PubMed ID: 21114638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of obsessive-compulsive disorder on the antimanic response to olanzapine therapy in youth with bipolar disorder.
    Joshi G; Mick E; Wozniak J; Geller D; Park J; Strauss S; Biederman J
    Bipolar Disord; 2010 Mar; 12(2):196-204. PubMed ID: 20402712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can pediatric bipolar disorder be successfully treated when comorbid with conduct disorder? A secondary analysis of clinical trials of risperidone, olanzapine, quetiapine, ziprasidone, and aripiprazole.
    Wozniak J; DiSalvo M; Farrell A; Yule A; Joshi G; Cook E; Faraone SV; Biederman J
    J Psychopharmacol; 2022 May; 36(5):637-644. PubMed ID: 35510655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examining the comorbidity of bipolar disorder and autism spectrum disorders: a large controlled analysis of phenotypic and familial correlates in a referred population of youth with bipolar I disorder with and without autism spectrum disorders.
    Joshi G; Biederman J; Petty C; Goldin RL; Furtak SL; Wozniak J
    J Clin Psychiatry; 2013 Jun; 74(6):578-86. PubMed ID: 23842009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Off-label second generation antipsychotics for impulse regulation disorders: a review.
    Scheltema Beduin A; de Haan L
    Psychopharmacol Bull; 2010; 43(3):45-81. PubMed ID: 21150846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review.
    Gao K; Muzina D; Gajwani P; Calabrese JR
    J Clin Psychiatry; 2006 Sep; 67(9):1327-40. PubMed ID: 17017818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open trial of bupropion for the treatment of adults with attention-deficit/hyperactivity disorder and bipolar disorder.
    Wilens TE; Prince JB; Spencer T; Van Patten SL; Doyle R; Girard K; Hammerness P; Goldman S; Brown S; Biederman J
    Biol Psychiatry; 2003 Jul; 54(1):9-16. PubMed ID: 12842303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second generation antipsychotics in Asperger's Disorder and high functioning autism: a systematic review of the literature and effectiveness of meta-analysis.
    Sochocky N; Milin R
    Curr Clin Pharmacol; 2013 Nov; 8(4):370-9. PubMed ID: 24050741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open-label, 8-week trial of olanzapine and risperidone for the treatment of bipolar disorder in preschool-age children.
    Biederman J; Mick E; Hammerness P; Harpold T; Aleardi M; Dougherty M; Wozniak J
    Biol Psychiatry; 2005 Oct; 58(7):589-94. PubMed ID: 16239162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comorbidity in pediatric bipolar disorder: prevalence, clinical impact, etiology and treatment.
    Frías Á; Palma C; Farriols N
    J Affect Disord; 2015 Mar; 174():378-89. PubMed ID: 25545605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone.
    Jing Y; Kim E; You M; Pikalov A; Tran QV
    J Med Econ; 2009 Jun; 12(2):104-13. PubMed ID: 19527195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychopharmacological treatment of non-comorbid and comorbid pervasive developmental disorder and pediatric bipolar disorder.
    Hamrin V; McDonnell MA; Moffett J; Durso S
    Minerva Pediatr; 2008 Feb; 60(1):87-101. PubMed ID: 18277368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of open-label, 8-week trials of olanzapine monotherapy and topiramate augmentation of olanzapine for the treatment of pediatric bipolar disorder.
    Wozniak J; Mick E; Waxmonsky J; Kotarski M; Hantsoo L; Biederman J
    J Child Adolesc Psychopharmacol; 2009 Oct; 19(5):539-45. PubMed ID: 19877978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and tolerability of switching to aripiprazole from risperidone in subjects with autism spectrum disorders: a prospective open-label study.
    Ishitobi M; Kosaka H; Takahashi T; Yatuga C; Asano M; Tanaka Y; Ueno K; Okazaki R; Omori M; Hiratani M; Tomoda A; Wada Y
    Clin Neuropharmacol; 2013; 36(5):151-6. PubMed ID: 24045605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of bipolar disorder comorbidity in adolescents and young adults with high-functioning autism spectrum disorder: a preliminary study of 44 outpatients.
    Munesue T; Ono Y; Mutoh K; Shimoda K; Nakatani H; Kikuchi M
    J Affect Disord; 2008 Dec; 111(2-3):170-5. PubMed ID: 18378000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of atypical antipsychotics for acute bipolar depression: a network meta-analysis.
    Kadakia A; Dembek C; Heller V; Singh R; Uyei J; Hagi K; Nosaka T; Loebel A
    BMC Psychiatry; 2021 May; 21(1):249. PubMed ID: 33975574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication patterns and costs associated with olanzapine and other atypical antipsychotics in the treatment of bipolar disorder.
    Zhu B; Kulkarni PM; Stensland MD; Ascher-Svanum H
    Curr Med Res Opin; 2007 Nov; 23(11):2805-14. PubMed ID: 17910804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The heavy burden of psychiatric comorbidity in youth with autism spectrum disorders: a large comparative study of a psychiatrically referred population.
    Joshi G; Petty C; Wozniak J; Henin A; Fried R; Galdo M; Kotarski M; Walls S; Biederman J
    J Autism Dev Disord; 2010 Nov; 40(11):1361-70. PubMed ID: 20309621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
    J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.